These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17005935)

  • 1. Renal damage after myocardial infarction is prevented by renin-angiotensin-aldosterone-system intervention.
    Windt WA; Eijkelkamp WB; Henning RH; Kluppel AC; de Graeff PA; Hillege HL; Schäfer S; de Zeeuw D; van Dokkum RP
    J Am Soc Nephrol; 2006 Nov; 17(11):3059-66. PubMed ID: 17005935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial infarction does not further impair renal damage in 5/6 nephrectomized rats.
    Windt WA; Henning RH; Kluppel AC; Xu Y; de Zeeuw D; van Dokkum RP
    Nephrol Dial Transplant; 2008 Oct; 23(10):3103-10. PubMed ID: 18503101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inter-individual differences in anti-proteinuric response to ACEi in established adriamycin nephrotic rats are predicted by pretreatment renal damage.
    Kramer AB; Laverman GD; van Goor H; Navis G
    J Pathol; 2003 Sep; 201(1):160-7. PubMed ID: 12950029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of osteopontin in proteinuria-induced renal interstitial fibrosis.
    Kramer AB; Ricardo SD; Kelly DJ; Waanders F; van Goor H; Navis G
    J Pathol; 2005 Dec; 207(4):483-92. PubMed ID: 16211543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renoprotective effects of VPI versus ACEI in normotensive nephrotic rats on different sodium intakes.
    Laverman GD; Van Goor H; Henning RH; De Jong PE; De Zeeuw D; Navis G
    Kidney Int; 2003 Jan; 63(1):64-71. PubMed ID: 12472769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopeptidase inhibition attenuates proteinuria and podocyte injury in Zucker diabetic fatty rats.
    Fredersdorf S; Weil J; Ulucan C; Birner C; Büttner R; Schubert T; Böger CA; Debl K; Muders F; Riegger GA; Luchner A
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Apr; 375(2):95-103. PubMed ID: 17333128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual inhibition of ACE and NEP provides greater cardioprotection in mice with heart failure.
    Xu J; Carretero OA; Liu YH; Yang F; Shesely EG; Oja-Tebbe N; Yang XP
    J Card Fail; 2004 Feb; 10(1):83-9. PubMed ID: 14966779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic blockade of angiotensin II action prevents glomerulosclerosis, but induces graft vasculopathy in experimental kidney transplantation.
    Smit-van Oosten A; Navis G; Stegeman CA; Joles JA; Klok PA; Kuipers F; Tiebosch AT; van Goor H
    J Pathol; 2001 May; 194(1):122-9. PubMed ID: 11329151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction.
    Ahmad M; White R; Tan J; Huang BS; Leenen FH
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):565-72. PubMed ID: 18496146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic resistance to angiotensin converting enzyme (ACE) inhibition is related to pharmacodynamic and -kinetic factors in 5/6 nephrectomized rats.
    Windt WA; van Dokkum RP; Kluppel CA; Jeronimus-Stratingh CM; Hut F; de Zeeuw D; Henning RH
    Eur J Pharmacol; 2008 Feb; 580(1-2):231-40. PubMed ID: 18036585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopeptidase inhibitor restores the balance of vasoactive hormones in progressive nephropathy.
    Benigni A; Zoja C; Zatelli C; Corna D; Longaretti L; Rottoli D; Maggioni P; Todeschini M; Noris M; Remuzzi G
    Kidney Int; 2004 Nov; 66(5):1959-65. PubMed ID: 15496167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats.
    Remuzzi A; Malanchini B; Battaglia C; Bertani T; Remuzzi G
    Exp Nephrol; 1996; 4(1):19-25. PubMed ID: 8788596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
    Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
    Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combining ACE inhibition with aldosterone blockade on proteinuria and renal damage in experimental nephrosis.
    Kramer AB; van der Meulen EF; Hamming I; van Goor H; Navis G
    Kidney Int; 2007 Mar; 71(5):417-24. PubMed ID: 17213874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse renal effects of the AGE inhibitor pyridoxamine in combination with ACEi in non-diabetic adriamycin-induced renal damage in rats.
    Waanders F; van Goor H; Navis G
    Kidney Blood Press Res; 2008; 31(5):350-9. PubMed ID: 19018148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibitors after renal transplantation.
    Bravo P; Felgueiras J; Santos C; Oliveira C; Ponce P
    Transplant Proc; 2008 Apr; 40(3):740-2. PubMed ID: 18455003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial infarction enhances progressive renal damage in an experimental model for cardio-renal interaction.
    van Dokkum RP; Eijkelkamp WB; Kluppel AC; Henning RH; van Goor H; Citgez M; Windt WA; van Veldhuisen DJ; de Graeff PA; de Zeeuw D
    J Am Soc Nephrol; 2004 Dec; 15(12):3103-10. PubMed ID: 15579513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The renal antifibrotic effects of angiotensin-converting enzyme inhibition involve bradykinin B2 receptor activation in angiotensin II-dependent hypertension.
    Seccia TM; Belloni AS; Guidolin D; Sticchi D; Nussdorfer GG; Pessina AC; Rossi GP
    J Hypertens; 2006 Jul; 24(7):1419-27. PubMed ID: 16794493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early, but not late therapy with a vasopressin V1a-antagonist ameliorates the development of renal damage after 5/6 nephrectomy.
    Windt WA; Tahara A; Kluppel AC; de Zeeuw D; Henning RH; van Dokkum RP
    J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):217-24. PubMed ID: 17347933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.